MedPath

Sodium Phenylbutyrate

Sodium Phenylbutyrate Powder (SO-dee-um fen-ill-BYOU-tih-rate) Rx Only

Approved
Approval ID

e914d451-6122-43f9-af8d-c80ed1cb215d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 2, 2022

Manufacturers
FDA

Sigmapharm Laboratories, LLC

DUNS: 556234636

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Phenylbutyrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42794-086
Application NumberANDA202819
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Phenylbutyrate
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 2, 2022
FDA Product Classification

INGREDIENTS (3)

CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
SODIUM PHENYLBUTYRATEActive
Quantity: 0.94 g in 1 g
Code: NT6K61736T
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Phenylbutyrate - FDA Drug Approval Details